Home LiteratureArticle Details
PMID: 3141287 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Killing of Brucella abortus by bovine serum.

Infection and immunity ·Vol. 56 ·No. 12 ·1988-12-00 ·Pages 3251-61

Corbeil LB, Blau K, Inzana TJ, Nielsen KH, Jacobson RH, Corbeil RR, Winter AJ

Abstract

Studies of the serum bactericidal system in bovine brucellosis were undertaken to investigate the role of the humoral immune response in protection of cattle against the facultative intracellular parasite Brucella abortus. Fresh sera from normal control cattle, infected cattle, and cattle immunized with B. abortus cell envelopes were collected before treatment and during the course of immunization or infection. Normal fresh bovine serum or fresh agammaglobulinemic serum from colostrum-deprived calves was effective in killing smooth virulent B. abortus 2308, but rough strains RB51 (a rough mutant of strain 2308) and 45/20 were much more sensitive to serum. The difference in susceptibility to serum was shown to be correlated with differences in lipopolysaccharide chemotype, with the more resistant strain 2308 having O polysaccharide and the more susceptible strains 45/20 and RB51 lacking O side chains. By treatment of fresh serum with MgCl2 and EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid] killing was shown to occur via the classical pathway of complement activation. When antibody to B. abortus was present, killing of strain RB51 increased but killing of smooth strain 2308 decreased. The earliest antibody response in serum from infected animals did not interfere with killing. When affinity-purified bovine immunoglobulins specific for B. abortus smooth lipopolysaccharide were added to fresh normal bovine serum, immunoglobulin G1 (IgG1) and IgG2 isotypes blocked killing but IgM and IgA isotypes did not. Thus, it appears that serum from previously unexposed animals or animals early during infection can kill smooth B. abortus, an appropriate defense mechanism before the organism becomes intracellular. At later stages of infection, blocking antibodies predominate.

MeSH Terms
Animals Antibodies, Bacterial/immunology Blood Bactericidal Activity Brucella abortus/immunology Brucellosis/immunology,veterinary Cattle Cattle Diseases/immunology Complement System Proteins/physiology Immunoglobulin Isotypes/immunology Lipopolysaccharides/immunology
Chemicals
Antibodies, Bacterial Immunoglobulin Isotypes Lipopolysaccharides Complement System Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Corbeil L B
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040.
Blau K
Inzana T J
Nielsen K H
Jacobson R H
Corbeil R R
Winter A J
References (56)
56 references, click to expand
  1. Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis.
    Ann Inst Pasteur Immunol. 1987 May-Jun;138(3):417-24 PMID: 3115279
  2. MICROCOLONY BRUCELLACIDAL TEST.
    J Bacteriol. 1961 May;81(5):684-7 PMID: 16561897
  3. Mechanisms of prozone formation in agglutination reaction.
    Can J Microbiol. 1972 Apr;18(4):449-56 PMID: 4112241
  4. The Bactericidal Action of Bovine Blood for Brucella and Its Possible Significance.
    J Bacteriol. 1945 Sep;50(3):261-77 PMID: 16560998
  5. Outer membrane proteins of Brucella abortus: isolation and characterization.
    Infect Immun. 1982 Mar;35(3):979-89 PMID: 6802764
  6. Immunoglobulin class specificity of non-agglutinating antibody produced in cattle following Brucella abortus 45/20 vaccination.
    Aust Vet J. 1975 Oct;51(10):481-3 PMID: 812466
  7. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  8. The effects of IgG2 and of antigen concentration on prozoning in the complement fixation test for bovine brucellosis.
    Res Vet Sci. 1977 Mar;22(2):194-7 PMID: 404679
  9. Killing of an encapsulated strain of Escherichia coli by human serum.
    Infect Immun. 1983 Jan;39(1):122-31 PMID: 6185430
  10. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum.
    Ann Immunol (Paris). 1977 Nov-Dec;128(6):1025-37 PMID: 413471
  11. Affinity purification of bovine antibodies to Brucella abortus Lipopolysaccharide.
    J Clin Microbiol. 1983 Feb;17(2):323-6 PMID: 6403576
  12. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Infect Immun. 1984 May;44(2):452-8 PMID: 6609128
  13. Serum susceptibility of bovine pasteurellas.
    Can J Vet Res. 1987 Apr;51(2):157-61 PMID: 3300919
  14. Antibody response to antigens distinct from smooth lipopolysaccharide complex in Brucella infection.
    Infect Immun. 1978 Sep;21(3):994-1002 PMID: 101470
  15. Biologic activities of bovine IgG subclasses.
    Adv Exp Med Biol. 1981;137:359-66 PMID: 7331944
  16. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum.
    J Exp Med. 1986 Nov 1;164(5):1735-48 PMID: 3095479
  17. Mechanism of immunity against brucella.
    Nature. 1965 Mar 13;205(976):1086-8 PMID: 4953576
  18. Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. II. Macrophages as target cells of poly A : U in experimental brucellosis.
    Immunology. 1978 Jul;35(1):77-84 PMID: 680804
  19. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies.
    Infect Immun. 1986 Mar;51(3):961-3 PMID: 3005173
  20. Protective effect of sera from animals treated with different Brucella antigens upon Brucella infection in mice.
    J Immunol. 1953 Oct;71(4):187-91 PMID: 13096757
  21. Localization of brucella antigens that elicit a humoral immune response in Brucella abortus-infected cells.
    Infect Immun. 1981 Dec;34(3):1000-7 PMID: 6800949
  22. Effects of various treatments of bovine complement on its lytic efficacy measured by two different tests.
    Vet Immunol Immunopathol. 1984 Jul;6(3-4):273-83 PMID: 6385462
  23. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    J Immunol. 1981 Nov;127(5):1748-54 PMID: 6795260
  24. Immunoglobulin patterns of antibodies against Brucella in man and animals.
    J Immunol. 1966 Mar;96(3):457-63 PMID: 4160424
  25. Lipopolysaccharide characteristics of pathogenic campylobacters.
    Infect Immun. 1985 Feb;47(2):353-9 PMID: 3967920
  26. Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants.
    Infect Immun. 1983 Dec;42(3):1159-67 PMID: 6315592
  27. Identification of immunoglobulins associated with complement fixation, agglutination, and low pH buffered antigen tests for brucellosis.
    Am J Vet Res. 1976 Mar;37(3):319-24 PMID: 3997
  28. Immune serum-mediated effects on brucellosis evolution in mice.
    Infect Immun. 1983 Jul;41(1):97-105 PMID: 6408007
  29. Effect of pregnancy on the immune response of cattle to a Brucella vaccine.
    J Reprod Immunol. 1986 Dec;9(4):313-25 PMID: 3820191
  30. The use of the antiglobulin test in the diagnosis of bovine brucellosis.
    Res Vet Sci. 1973 Mar;14(2):239-44 PMID: 4217918
  31. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
    Microbiol Rev. 1983 Mar;47(1):46-83 PMID: 6343827
  32. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement.
    Vet Immunol Immunopathol. 1983 Nov;5(1):65-76 PMID: 6419447
  33. The epidemiology of bovine brucellosis.
    Adv Vet Sci Comp Med. 1980;24:69-98 PMID: 6779513
  34. A turbidity test for the estimation of immune globulin levels in neonatal calf serum.
    Clin Chim Acta. 1970 Jan;27(1):155-63 PMID: 4189647
  35. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.
    Eur J Cancer. 1979;15 Suppl:71-6 PMID: 397063
  36. Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae.
    J Infect Dis. 1983 Sep;148(3):492-9 PMID: 6604761
  37. An immunological enhancement phenomenon in experimental brucella infection of the chicks.
    Int Arch Allergy Appl Immunol. 1977;53(2):190-4 PMID: 403146
  38. Susceptibility of Pasteurella haemolytica to the bactericidal effects of serum, nasal secretions and bronchoalveolar washings from cattle.
    Vet Microbiol. 1983 Nov;8(6):585-99 PMID: 6419445
  39. Evidence of heterogeneity of lipopolysaccharides among Brucella biovars in relation to A and M specificities.
    Ann Inst Pasteur Microbiol. 1987 Jan-Feb;138(1):27-37 PMID: 3300718
  40. Ethylenediaminetetraacetic acid (disodium salt)-labile bovine immunoglobulin M Fc binding to Brucella abortus: a cause of nonspecific agglutination.
    J Clin Microbiol. 1981 Jul;14(1):32-8 PMID: 6790568
  41. Blocking serum lysis of Brucella abortus by hyperimmune rabbit immunoglubulin A.
    J Immunol. 1971 Jul;107(1):41-6 PMID: 4103920
  42. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus.
    J Bacteriol. 1979 May;138(2):361-9 PMID: 108257
  43. Failure of bovine complement levels measured by radial hemolysis to correlate with tube titration.
    Am J Vet Res. 1983 Oct;44(10):1935-7 PMID: 6416118
  44. Enhancement activity of anti-brucella sera in experimental Brucella abortus infection in mice.
    Rev Can Biol. 1977 Sep;36(3):239-43 PMID: 412235
  45. Biological activities of Brucella abortus lipopolysaccharides.
    Infect Immun. 1981 Jan;31(1):362-70 PMID: 6783538
  46. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Immunology. 1978 Aug;35(2):213-21 PMID: 750371
  47. Assessment of bovine mammary gland macrophage oxidative burst activity in a chemiluminescence assay.
    Am J Vet Res. 1987 Jan;48(1):119-25 PMID: 3826830
  48. The relationships of pregnancy hormones to brucellacidal activity in bovine serum.
    Am J Vet Res. 1962 Sep;23:1027-30 PMID: 13869050
  49. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.
    Ann Intern Med. 1979 Jun;90(6):917-20 PMID: 109025
  50. Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.
    J Immunol. 1975 Jun;114(6):1779-84 PMID: 805178
  51. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.
    Infect Immun. 1986 Aug;53(2):245-51 PMID: 3089933
  52. Failure of colostral immunoglobulin transfer in calves dying from infectious disease.
    J Am Vet Med Assoc. 1976 Oct 1;169(7):713-8 PMID: 987032
  53. Role of blocking antibody in disseminated gonococcal infection.
    J Immunol. 1978 Nov;121(5):1884-8 PMID: 712069
  54. Serum susceptibility of Haemophilus somnus from bovine clinical cases and carriers.
    J Clin Microbiol. 1985 Aug;22(2):192-8 PMID: 4031034
  55. Outer membrane proteins from rough strains of four Brucella species.
    Infect Immun. 1984 Oct;46(1):188-94 PMID: 6480106
  56. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Anal Biochem. 1982 Jan 1;119(1):115-9 PMID: 6176137
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1988-12-00
Pages
3251-61
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259732
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com